Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assessing the Effects of Hormones on Noninvasive Transcranial Stimulation

NCT: NCT07635017 · NOT_YET_RECRUITING

NCT IDNCT07635017
StatusNOT_YET_RECRUITING
Start Date2026-07-01
Completion2028-07-01
SponsorCarnegie Mellon University (OTHER)
First posted
Last updated

Brief Summary

This study is investigating how two types of non-invasive brain stimulation, transcranial electrical stimulation (TES) and transcranial magnetic stimulation (TMS), affect brain activity, and whether combining them produces stronger or more consistent effects than either one used alone. The motivation for this comes from the observation that TMS, which is FDA-approved for treating depression, tends to work less well in postmenopausal women because lower estrogen levels reduce the brain's ability to respond to stimulation. The research team believes that pairing TMS with TES, which targets a different set of brain cells, may be able to overcome this hormonal barrier and make stimulation more effective. Participants will come into the lab for up to 24 visits over 8 months, beginning with an initial visit to establish the right stimulation settings, followed by a series of stimulation sessions in which brain activity is measured before and after receiving either TES, TMS, or both together. For female participants, sessions will be scheduled at specific points in the menstrual cycle to capture the natural monthly rise and fall of estrogen, while male participants will be scheduled on a comparable fixed interval as a comparison group. The insights gained from this study could directly inform the development of better, more reliable brain stimulation treatments for women with depression.

Frequently Asked Questions

What is Assessing the Effects of Hormones on Noninvasive Transcranial Stimulation?

Assessing the Effects of Hormones on Noninvasive Transcranial Stimulation is a clinical trial registered under NCT07635017. Current status: NOT_YET_RECRUITING.

What is the status of NCT07635017?

The current status of NCT07635017 (Assessing the Effects of Hormones on Noninvasive Transcranial Stimulation) is: NOT_YET_RECRUITING.

When did Assessing the Effects of Hormones on Noninvasive Transcranial Stimulation start?

Assessing the Effects of Hormones on Noninvasive Transcranial Stimulation started on 2026-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.